Literature DB >> 14583381

Role of tachykinin NK1, NK2 and NK3 receptors in the modulation of visceral hypersensitivity in the rat.

Geneviève-Anne Gaudreau1, Victor Plourde.   

Abstract

Tachykinins are known to be involved in the processing of information leading to central sensitization and nociception. Using an animal model of repetitive colorectal distensions (CRD), we investigated the effect of spinal administration of tachykinin receptor antagonists in the mediation of visceral hypersensitivity. Intrathecal administration of the NK(1) receptor antagonist RP-67,580 (6.5 nmol) and the NK(3) receptor antagonist R-820 (6.5 nmol) completely blocked the CRD-induced hyperalgesia for both noxious and innocuous stimuli. The intrathecal administration of SR-48,968, a tachykinin NK(2) receptor antagonist, did not affect the visceral pain threshold of hypersensitive animals. Thus, the results from the present experiment support the concept that tachykinins with actions at spinal NK(1) and NK(3) but not NK(2) receptor sites are involved in visceral hypersensitivity mediated by nociceptive and non-nociceptive afferent inputs.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14583381     DOI: 10.1016/s0304-3940(03)00414-2

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  11 in total

1.  Evidence for mediation of nociception by injection of the NK-3 receptor agonist, senktide, into the dorsal periaqueductal gray of rats.

Authors:  Gabriel S Bassi; Ana C Broiz; Margarete Z Gomes; Marcus L Brandão
Journal:  Psychopharmacology (Berl)       Date:  2008-12-18       Impact factor: 4.530

Review 2.  Stress and visceral pain: from animal models to clinical therapies.

Authors:  Muriel Larauche; Agata Mulak; Yvette Taché
Journal:  Exp Neurol       Date:  2011-05-06       Impact factor: 5.330

3.  Characteristics of intestinal microflora involved insacral nerve stimulation affecting visceral hypersensitivity.

Authors:  Zhi He; Bixing Ye; Yu Ding; Liuqin Jiang
Journal:  Int J Clin Exp Pathol       Date:  2019-07-01

4.  Activation of tachykinin, neurokinin 3 receptors affects chromatin structure and gene expression by means of histone acetylation.

Authors:  Amit Thakar; Elise Sylar; Francis W Flynn
Journal:  Peptides       Date:  2012-09-15       Impact factor: 3.750

Review 5.  Visceral pain: the neurophysiological mechanism.

Authors:  Jyoti N Sengupta
Journal:  Handb Exp Pharmacol       Date:  2009

Review 6.  Neurokinin NK1 and NK3 receptors as targets for drugs to treat gastrointestinal motility disorders and pain.

Authors:  Gareth J Sanger
Journal:  Br J Pharmacol       Date:  2004-03-15       Impact factor: 8.739

Review 7.  Tachykinin NK2 receptor antagonists for the treatment of irritable bowel syndrome.

Authors:  Alessandro Lecci; Angela Capriati; Carlo Alberto Maggi
Journal:  Br J Pharmacol       Date:  2004-03-22       Impact factor: 8.739

8.  Stress-related alterations of visceral sensation: animal models for irritable bowel syndrome study.

Authors:  Muriel Larauche; Agata Mulak; Yvette Taché
Journal:  J Neurogastroenterol Motil       Date:  2011-07-13       Impact factor: 4.924

Review 9.  The Role of Visceral Hypersensitivity in Irritable Bowel Syndrome: Pharmacological Targets and Novel Treatments.

Authors:  Mohammad H Farzaei; Roodabeh Bahramsoltani; Mohammad Abdollahi; Roja Rahimi
Journal:  J Neurogastroenterol Motil       Date:  2016-10-30       Impact factor: 4.924

Review 10.  Experimental Models of Irritable Bowel Syndrome and the Role of the Enteric Neurotransmission.

Authors:  Maria Giuliana Vannucchi; Stefano Evangelista
Journal:  J Clin Med       Date:  2018-01-03       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.